The current study focusing on CHC patients may echo the report that the PNPLA3 rs738409 GG genotype increases the risk of NAFLD in the general population without metabolic disorder14. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.